Latest filing published 13 May 2025 for Bastide le Confort Medical, €25k. Read the official filing
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Vincent BASTIDE on record concern Bastide le Confort Medical, in the capacity of chief executive. In total, 7 filings cover trades dated from 22 March 2023 to 11 April 2025.
No open-market sale appears; the market trades are 6 purchases worth €194k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant. In 2025 alone, the filings show 5 purchases and no sales.
A typical purchase (the median) is worth €26k. None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +27.9%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 13 May 2025, the filings show an open-market purchase worth €25k in Bastide le Confort Medical. Between a trade and the moment it shows up on AMF, the median delay is 5 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations